First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

NCT05768139 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

880

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Solid Tumors, Adult

Interventions

DRUG: STX-478
DRUG: Fulvestrant
DRUG: Ribociclib
DRUG: Palbociclib
DRUG: Letrozole
DRUG: Anastrozole
DRUG: Exemestane
DRUG: Tamoxifen
DRUG: Abemaciclib
DRUG: Imlunestrant
DRUG: Metformin

Sponsor

Eli Lilly and Company